Alzheimer’s research in the United States is a massive, multi-billion-dollar ecosystem led by a mix of federal agencies, non-profit foundations, and elite academic medical centers.

Welcome to the GlassBury Insight Series. As we navigate the midpoint of 2026, the landscape of neurodegenerative research has shifted from cautious optimism to a full-throttle revolution. The "inevitability" of cognitive decline is being dismantled by a new guard of precision diagnostics and bio-digital interventions.

Mental health is a vital part of our overall well-being, yet it's often shrouded in stigma and faces numerous challenges in terms of diagnosis and treatment.